Kite Appoints Frank Neumann as Worldwide Head of Clinical Development

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/29/2026

1. V
2. KLAC
3. SPY
4. PYPL
5. CSGP
6. BE
7. SWKS
8. F
9. STX
10. VRNS

Go back to Kite Appoints Frank Neumann as Worldwide Head of Clinical Development
Gilead Sciences (NASDAQ: GILD) Delayed: 132.73 -1.59 (1.18%)
Previous Close $134.32    52 Week High $108.63 
Open $134.41    52 Week Low $71.39 
Day High $134.64    P/E 73.33 
Day Low $132.57    EPS $1.81 
Volume 6,675,248